SOMATREM for Hypothalamo-pituitary disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where SOMATREM was used for Hypothalamo-pituitary disorder.
Most Reported Side Effects for SOMATREM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Clear cell renal cell carcinoma | 51 | 31.3% | 1 | 1 |
| Lymphoproliferative disorder | 51 | 31.3% | 1 | 1 |
| Off label use | 46 | 28.2% | 1 | 1 |
| Product use in unapproved indication | 32 | 19.6% | 1 | 1 |
| Renal cell carcinoma | 25 | 15.3% | 0 | 0 |
| Drug dose omission | 14 | 8.6% | 0 | 5 |
| Growth retardation | 14 | 8.6% | 0 | 2 |
| Malaise | 14 | 8.6% | 0 | 9 |
| Seizure | 11 | 6.8% | 1 | 3 |
| Hair follicle tumour benign | 10 | 6.1% | 1 | 1 |
| Pain | 10 | 6.1% | 0 | 2 |
| Off label use of device | 9 | 5.5% | 0 | 0 |
| Pyrexia | 9 | 5.5% | 1 | 5 |
| Weight increased | 9 | 5.5% | 0 | 2 |
| Headache | 8 | 4.9% | 0 | 5 |
Other Indications for SOMATREM
Product used for unknown indication (58)
Growth hormone deficiency (42)
Dwarfism (35)
Hypopituitarism (22)
Body height below normal (7)
Turner's syndrome (7)
Other Drugs Used for Hypothalamo-pituitary disorder
SOMATROPIN (633)
PEGVISOMANT (41)
HYDROCORTISONE (25)
DEXTROAMPHETAMINE (22)
CETRORELIX (17)
LANREOTIDE (11)
OCTREOTIDE (11)
FOLLITROPIN BETA (10)
LEUPROLIDE (10)
TESTOSTERONE (8)